| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/27/2003 | US6569890 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/27/2003 | US6569888 Such as ethyl-N-(dichlorobenzyl)-4-(3-hydroxypropylthio) indole-2-carboxylate; for treatment of arthritis |
| 05/27/2003 | US6569885 Cyclic AMP-specific phosphodiesterase inhibitors |
| 05/27/2003 | US6569871 Substituted imidazole compounds |
| 05/27/2003 | US6569860 Alkoxycarbonylamino-heteroaryl carboxylic acid derivatives useful for treating the disorders of the urinary tract, pain, inflammation, respiratory states, edema formation, hypotensive vascular diseases, pain and allergies |
| 05/27/2003 | US6569850 Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tyrptophan and possibly a vitamin B12 compound |
| 05/27/2003 | US6569847 Inhibitors of cathepsins for treating muscular dystrophy, osteoporosis, rheumatoid arthritis, neuronal or cardiac ischaemia, allergy, or Chagas disease |
| 05/27/2003 | US6569665 Genetic engineering; enzymatic inhibitor screening; use of calpain inhibitors in treatment of neurodegenerative disease |
| 05/27/2003 | US6569467 Modifying extracted blood aliquot extracorporeally by subjecting it to an immune system-modifying amount of ozone gas and ultraviolet radiation; reinjecting the vaccine into the patient; rheumatoid arthritis, psoriasis |
| 05/27/2003 | US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides |
| 05/27/2003 | US6569431 Polypeptide for use in the treatment of autoimmune disease and multiple sclerosis |
| 05/27/2003 | US6569429 Isolated polypeptide comprising the amino acid residues 1 to 344 of (SEQ ID NO: 2); systemic lupus erythematosus; pulmonary disease or disorder |
| 05/27/2003 | US6569424 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 05/27/2003 | US6569420 Human interferon-ε: a type I interferon |
| 05/27/2003 | US6569112 Extracorporeal affinity adsorption device |
| 05/27/2003 | CA2273855C Novel feline fc epsilon receptor alpha chain nucleic acid molecules, proteins and uses thereof |
| 05/27/2003 | CA2231558C .gamma.-rar antagonist ligand or .alpha.-rar agonist ligand as an apoptosis inhibitor |
| 05/27/2003 | CA2176229C Improved interferon polymer conjugates |
| 05/27/2003 | CA2158455C Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide and their uses in vaccines and disease treatments |
| 05/27/2003 | CA2145169C A process for the purification of aqueous extracts containing allergenically active proteins, extracts obtainable according to this process as well as their use |
| 05/27/2003 | CA2031430C Process for refolding recombinantly produced tgf-.beta.-like proteins |
| 05/22/2003 | WO2003042397A2 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby |
| 05/22/2003 | WO2003042390A1 Mammalian protein phosphatases |
| 05/22/2003 | WO2003042381A1 Three-dimensional structure of prostaglandin d synthase and utilization thereof |
| 05/22/2003 | WO2003042377A1 Expansion of t cells in vitro and expanded t cell populations |
| 05/22/2003 | WO2003042359A2 Histamine receptor h3 polynucleotides |
| 05/22/2003 | WO2003042357A2 Enzymes |
| 05/22/2003 | WO2003042344A2 Apo2 ligand/trail formulations |
| 05/22/2003 | WO2003042216A1 Polycyclic guanine derivative phosphodiesterase v inhibitors |
| 05/22/2003 | WO2003042205A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042191A1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 05/22/2003 | WO2003042190A1 N-alkyl-adamantyl derivatives as p2x7-receptor antagonists |
| 05/22/2003 | WO2003042187A1 Serin protease inhibitors |
| 05/22/2003 | WO2003042178A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 05/22/2003 | WO2003042177A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 05/22/2003 | WO2003042174A1 Cannabinoid receptor ligands |
| 05/22/2003 | WO2003042171A1 Vitamin d derivatives with acyloxy groups at the 24-position of the side chain, a method for producing the same and use thereof in production of medicaments |
| 05/22/2003 | WO2003041723A1 Pharmaceutical applications of hyaluronic acid preparations |
| 05/22/2003 | WO2003041721A1 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 05/22/2003 | WO2003041715A1 Substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer |
| 05/22/2003 | WO2003041708A1 Benzimidazoles useful as protein kinase inhibitors |
| 05/22/2003 | WO2003041702A1 Production of pure stereoisomers of tricyclo[5.2.1.02.6]-dec-9-yl xanthogenate and medicaments therefrom |
| 05/22/2003 | WO2003041697A1 Method for treating autoimmune diseases |
| 05/22/2003 | WO2003041684A2 Injectable depot compositions and uses thereof |
| 05/22/2003 | WO2003041649A2 Cyanoalkylamino derivatives as protease inhibitors |
| 05/22/2003 | WO2003041563A2 Neurotransmitter balance chemotherapy |
| 05/22/2003 | WO2003020763A3 Soluble t cell receptor |
| 05/22/2003 | WO2003020253A3 Pharmaceutical compositions for the treatment of asthma |
| 05/22/2003 | WO2003011277A3 Methods to mobilize progenitor/stem cells |
| 05/22/2003 | WO2002100327A3 Substituted 1-benzazepines and derivatives thereof |
| 05/22/2003 | WO2002098438A9 Compositions containing an active fraction isolated from scutellariae barbatae and methods of use |
| 05/22/2003 | WO2002078766A3 Combination therapy |
| 05/22/2003 | WO2002058737A3 Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 05/22/2003 | WO2002051430A3 Methods of modulating toll-related receptor (trr) signaling |
| 05/22/2003 | WO2002044183A3 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 05/22/2003 | WO2002044168A3 Indole-type inhibitors of p38 kinase |
| 05/22/2003 | WO2002030924A9 Quinazoline derivatives with anti-tumour activity |
| 05/22/2003 | WO2002022807A3 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 05/22/2003 | WO2001070941A9 An infective endogenous retrovirus in association with demyelinating diseases e.g. multiple sclerosis |
| 05/22/2003 | WO2000037429A3 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 05/22/2003 | US20030097023 For prophylaxis and therapy of immunological diseases, asthma, abnormal bone formation, neuronal cell death, lung failure, liver damage, acute hepatitis, nephritis, renal insufficiency, hypertension, myocardiac ischemia |
| 05/22/2003 | US20030097004 3,4-Di-substituted cyclobutene-1,2-diones as CXC chemokine receptor antagonists |
| 05/22/2003 | US20030096998 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections |
| 05/22/2003 | US20030096992 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/22/2003 | US20030096860 Benzopyran derivative and antiallergic agent |
| 05/22/2003 | US20030096844 Cannabinoid receptor ligands |
| 05/22/2003 | US20030096841 For treatment of cancers, heart disease, such as congestive heart failure, osteoporosis, genetic, inflammatory, allergic, and autoimmune diseases |
| 05/22/2003 | US20030096840 Granule formulation |
| 05/22/2003 | US20030096835 Amido ether substituted imidazoquinolines |
| 05/22/2003 | US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function |
| 05/22/2003 | US20030096829 1-biaryl-1,8-naphthyridin-4-one phosphodiesterase-4 inhibitors |
| 05/22/2003 | US20030096828 Cyclic amide compound |
| 05/22/2003 | US20030096827 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 05/22/2003 | US20030096825 Antiviral activity; treatment of HIV and AIDS |
| 05/22/2003 | US20030096819 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents |
| 05/22/2003 | US20030096817 Inhibiting mammalian protein kinases (p38) with (2,6-difluoro-phenyl)-(5-iodo-pyridin-2-yl)amine for treatment of cardiovascular disorders |
| 05/22/2003 | US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents |
| 05/22/2003 | US20030096811 Such as cis-(4-dimethylaminomethyl-3-hydroxy-3-(3-methoxy-phenyl)-cyclohexanone for treatment of pain, inflammation, allergies, depression, drug/alcohol abuse, gastritis, itching, cardiovascular/repiratory diseases, epilepsy, and diarrhea |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096795 Calcium (3S) tetrahydro-3-furanyl (1S,2R)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phos-phonooxy)propylcarbamate |
| 05/22/2003 | US20030096783 21132, a human G-protein coupled receptor family member and uses therefor |
| 05/22/2003 | US20030096779 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies |
| 05/22/2003 | US20030096758 Anticarcinogenic agents |
| 05/22/2003 | US20030096756 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096739 Nuclear receptor-mediated introduction of a PNA into cell nuclei |
| 05/22/2003 | US20030096737 Caspase inhibitors and uses thereof |
| 05/22/2003 | US20030096705 Antagonists of MCP-1 function and methods of use thereof |
| 05/22/2003 | US20030096370 Gram negative bacterial protein for use in the prevention and treatment of bacterial infection |
| 05/22/2003 | US20030096369 Non-anaphylactogenic IgE vaccines |
| 05/22/2003 | US20030096352 Nucleotide sequences coding polypeptides for use in the treatment and prevention of viral and bacterial disease |
| 05/22/2003 | US20030096350 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/22/2003 | US20030096311 Detection of allergic response in humans; obtain interferon sample, incubate wot test agent, detect conjugation between interferon and agent, conjugation indicates induction of allergies |
| 05/22/2003 | US20030096299 Natural ligand of G protein coupled receptor ChemR23 and uses thereof |
| 05/22/2003 | US20030096297 Method for identifying inhibitors of G protein coupled receptor signaling |
| 05/22/2003 | US20030096029 Remedies for allergic diseases and process for producing the same |
| 05/22/2003 | US20030096027 Alpha acid, (e.g., humulone) or beta acid (e.g., lupulone) |
| 05/22/2003 | US20030096025 Oolong tea extract |
| 05/22/2003 | US20030096016 Methods of kidney transplantation utilizing developing nephric tissue |
| 05/22/2003 | US20030096002 Delivery system for biological component |
| 05/22/2003 | US20030095997 Preferably collagen; capable of promoting formation of granulation tissue, angiogenesis, vascularization and epithelization; useful in surgical suturing. |